Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study

The aim of the study was to evaluate efficacy and tolerability of two different fixed combinations of an angiotensin-converting enzyme inhibitor and a diuretic: delapril+indapamide (D+I) and captopril+hydrochlorothiazide (C+H) administered for 6 months to patients with mild to moderate essential hyp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of human hypertension 2003-02, Vol.17 (2), p.139-146
Hauptverfasser:	Rosei, E A, Rizzoni, D
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Adolescent Adult Aged Angiotensin Angiotensin-converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - administration & dosage Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Antihypertensive Agents - administration & dosage Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Antihypertensives Biological and medical sciences Blood pressure Captopril - administration & dosage Captopril - adverse effects Captopril - therapeutic use Cardiovascular system Diuretics Dosage and administration Drug Combinations Drug therapy Epidemiology Essential hypertension Female Health Administration Humans Hydrochlorothiazide Hydrochlorothiazide - administration & dosage Hydrochlorothiazide - adverse effects Hydrochlorothiazide - therapeutic use Hypertension Hypertension - drug therapy Indans - administration & dosage Indans - adverse effects Indans - therapeutic use Indapamide Indapamide - administration & dosage Indapamide - adverse effects Indapamide - therapeutic use Male Medical sciences Medicine Medicine & Public Health Middle Aged original-article Patients Peptidyl-dipeptidase A Pharmacology. Drug treatments Physiological aspects Public Health Severity of Illness Index Tablets
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!